Revolutionary FDA Approval Marks Medical Milestone
Startup Clairity has achieved a groundbreaking milestone in healthcare technology, securing FDA approval for the agency’s first artificial intelligence tool specifically designed to predict five-year breast cancer risk from…
Major FDA Milestone for Pediatric Care
The U.S. Food and Drug Administration has granted pediatric approval for GE HealthCare’s Optison, marking a significant advancement in pediatric cardiac imaging. This ultrasound enhancing agent will now help…
Promise and Paradox in Cell Therapy Growth
Cell and gene therapies (CGTs) stand at the precipice of transformative growth, with Cardinal Health’s “2025 Advanced Therapies Report” projecting over 200 FDA-approved treatments and 100,000+ U.S. patients…
Bipartisan Legislation Targets Healthcare Innovation
Groundbreaking bipartisan legislation has been reintroduced by Senators Capito and Shaheen that could transform Medicare’s approach to digital therapeutics. The Access to Prescription Digital Therapeutics Act of 2023 aims to…
Healthcare Organizations Embrace AI at Unprecedented Rates
Healthcare is experiencing a dramatic shift toward artificial intelligence, with 70% of healthcare payers and providers now actively implementing generative AI technologies. This represents a significant move beyond…
Guidelines and guardrails for the safe use of AI require more than regulation. The Coalition for Health AI has created a framework to reduce these risks and improve the safety and effectiveness of these…
Continue Reading
BREAKTHROUGH EXPANSION FOR PROSTATE CANCER THERAPY
Novartis has announced a significant development in prostate cancer treatment with the FDA‘s expanded approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan). This radioligand therapy is now available for…
Breakthrough Cancer Treatment Receives IDE Approval
Alpha Tau Medical Ltd. has achieved a significant milestone in cancer treatment innovation. The FDA has granted an Investigational Device Exemption (IDE) for a pilot study using their revolutionary…
